Medicated Skin Care in Venezuela
Vaginal and topical antifungals represented a 72% share of medicated skin care value sales in 2011. Both have been two of the most dynamic categories in consumer health over the review period. Although innovation has been seriously limited in the entire industry due to regulatory constraints, Bayer launched a new format of its successful vaginal antifungal brand Gynocasten and also introduced a new topical antifungal named Canesfast. These categories benefit from large-scale advertising...
Euromonitor International's Medicated Skin Care in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Medicated Skin Care in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Medicated Skin Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 6 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Konsuma De Venezuela SA in Consumer Health (venezuela)
Strategic Direction
Key Facts
Summary 1 Konsuma de Venezuela SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Konsuma de Venezuela SA: Competitive Position 2011
Laboratorios Elmor SA in Consumer Health (venezuela)
Strategic Direction
Key Facts
Summary 3 Laboratorios Elmor SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Laboratorios Elmor SA: Competitive Position 2011
Vargas Ca in Consumer Health (venezuela)
Strategic Direction
Key Facts
Summary 5 Vargas CA: Key Facts
Company Background
Production
Competitive Positioning
Summary 6 Vargas CA: Competitive Position 2011
Executive Summary
Consumer Health Value Sales Decrease in A Negative Economic Context
Business Climate Remains A Major Obstacle To Market Development
Competition Remains Strong With Six Multinationals Among the Top Ten
Parapharmacies/drugstores Lead Distribution Channels in 2011
Low Value Growth Thanks To Continuation of Current Economic Policies
Key Trends and Developments
Adverse Regulatory Framework Limits Innovation and Product Availability
Consumption Remains Constrained Thanks To Slow Economic Growth
Companies Rely on Educational Campaigns To Encourage Self-medication
Venezuelan Population Is Mainly Young, Although Rapidly Ageing
Consumer Health Companies Enter the Arena of Social Networks
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 7 Research Sources
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 6 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Konsuma De Venezuela SA in Consumer Health (venezuela)
Strategic Direction
Key Facts
Summary 1 Konsuma de Venezuela SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Konsuma de Venezuela SA: Competitive Position 2011
Laboratorios Elmor SA in Consumer Health (venezuela)
Strategic Direction
Key Facts
Summary 3 Laboratorios Elmor SA: Key Facts
Company Background
Production
Competitive Positioning
Summary 4 Laboratorios Elmor SA: Competitive Position 2011
Vargas Ca in Consumer Health (venezuela)
Strategic Direction
Key Facts
Summary 5 Vargas CA: Key Facts
Company Background
Production
Competitive Positioning
Summary 6 Vargas CA: Competitive Position 2011
Executive Summary
Consumer Health Value Sales Decrease in A Negative Economic Context
Business Climate Remains A Major Obstacle To Market Development
Competition Remains Strong With Six Multinationals Among the Top Ten
Parapharmacies/drugstores Lead Distribution Channels in 2011
Low Value Growth Thanks To Continuation of Current Economic Policies
Key Trends and Developments
Adverse Regulatory Framework Limits Innovation and Product Availability
Consumption Remains Constrained Thanks To Slow Economic Growth
Companies Rely on Educational Campaigns To Encourage Self-medication
Venezuelan Population Is Mainly Young, Although Rapidly Ageing
Consumer Health Companies Enter the Arena of Social Networks
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 7 Research Sources
